![A person holding a vial of insulin](/sites/default/files/media_2022/04/202204us_bhr_insulin_zoe_novolog.jpg)
Zoe Witt, a type 1 diabetic in Seattle, Washington, holds a 10-milliliter vial of Novolog, a name-brand insulin analog produced by the Danish company Novo Nordisk.
© 2022 Bella Petro
Zoe Witt, a type 1 diabetic in Seattle, Washington, holds a 10-milliliter vial of Novolog, a name-brand insulin analog produced by the Danish company Novo Nordisk.